- CA$1.09bn
- CA$1.23bn
- CA$629.77m
- 89
- 49
- 79
- 84
Annual income statement for Heroux Devtek, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 613 | 571 | 536 | 544 | 630 |
| Cost of Revenue | |||||
| Gross Profit | 103 | 94.9 | 91.1 | 73.5 | 111 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 640 | 535 | 488 | 516 | 571 |
| Operating Profit | -26.9 | 35.7 | 47.8 | 27.4 | 59.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -37.9 | 26.2 | 40.5 | 18.6 | 45.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -46.9 | 19.8 | 32.1 | 13.8 | 38.3 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -50.1 | 20.1 | 32.5 | 13.8 | 38.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -50.1 | 20.1 | 32.5 | 13.8 | 38.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.147 | 0.378 | 0.641 | 0.227 | 0.833 |